Introduction
Due to aggressive progression and numerous complications, severe acute pancreatitis (SAP) has a high mortality rate. Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are known as the 2 major causes of death among SAP patients (1) . Since the gut is considered to be a "critical organ" of SIRS as well as an "amplifier" of inflammatory mediators (2) , intestinal mucosa dysfunction may play an important role in the pathophysiology of SAP (3).
Therefore, serum levels of DAO, endotoxin and permeability of intestinal epithelial monolayer are detected together to reflect changes in intestinal mucosal barrier function (7) .
Continuous blood purification (CBP) has been used to save critically ill patients in the ICU. In recent years, numerous clinical studies have demonstrated that CBP therapy has shown a beneficial effect in the treatment of SAP (8, 9) . The therapeutic mechanisms of CBP include the removal of inflammatory mediators and excessive fluid and redressing other organ functions besides renal function (10, 11) . However, there are also some potential mechanisms that remain unclear. Previously, we investigated the effect of CBP therapy on intestinal epithelial cells in SAP patients in vitro (12) . The present study was aimed at using in vivo and in vitro experiments to investigate the effect of CBP on the intestinal mucosal barrier in SAP patients with MODS and at further elucidating the potential mechanism.
Materials and methods

Patients
A total of 45 cases of SAP patients with MODS (28 male and 17 female, with an average age of 49.24 ± 17.25 years) who were admitted to our hospital from January 2012 to July 2015 were selected for the study. The diagnosis of SAP was in accordance with Atlanta International Conference criteria on Pancreatic Diseases in 1992 (13) . SAP is defined as acute pancreatitis associated with organ dysfunction, or necrosis, abscess or pseudocyst and other local complications, or both. It can be complicated by 1 or more organ dysfunction, but also associated with severe metabolic disorders, including hypocalcemia and acute Physiology and chronic Health Evaluation II (APACHE II) score above 8. MODS was diagnosed if dysfunction of more than 1 organ was detected, requiring intervention to maintain homeostasis (14, 15) . The diagnosis of acute renal failure (AFR) was in accordance with KDIGO clinical practice guidelines for acute kidney injury in 2012 (16) . AFR is defined clinically by an increase in serum creatinine by ≥0.3 mg/dL (≥26.5 umol/L) within 48 hours, or by an increase in serum creatinine to ≥1.5 times baseline within the previous 7 days, or by urine volume ≤0.5 mL/kg/h for 6 hours. The incidence of organ dysfunction in all patients is summarized in Table I . In addition, 20 healthy volunteers matched for age and sex (including 12 male and 8 female, with an average age of 46.30 ± 7.51 years old) served as control subjects. All the patients were admitted to the ICU and received conventional treatments such as fasting and fluid resuscitation, gastrointestinal decompression, gastric acid and pancreatic secretion inhibition (somatostatin), anti-infection, nutritional supplementation and oxygen therapy (14 patients underwent mechanical ventilation by noninvasive methods and 12 patients underwent mechanical ventilation by endotracheal intubation or tracheotomy). Vasoactive agents may have been used in some of the patients to stabilize the blood pressure. Commencement of the continuous blood purification (CBP) procedure was started within 4 hours after fulfillment of SAP with MODS criteria. Blood samples were collected before CBP and after CBP to observe hepatic function, renal function, coagulation function and arterial blood gas, etc. The APACHE II score was determined before CBP and after CBP. The study was approved by the ethics committee of the hospital and informed consent was obtained.
Continuous blood purification treatment
Patients were treated with CBP for 24 hours. According to the disease, CBP treatment was repeated 2-5 times. A double lumen catheter was inserted into the patients' femoral central vein to establish vascular access. Continuous venovenous hemofiltration (CVVH) was performed with a roller blood pump and digital fluid flow control system (Prismaflex system; Gambro). The filter used for CVVH was a high-flux polysulphone membrane (AN69, with effective surface area of 1.6 m2, 35 KDa limit; Gambro). Based on the patients' blood pressure, the blood flow rate was kept between 180 and 300 mL/min. The replacement fluid was infused at a rate of 4,000 mL/h in a pre-diluted manner. 1.56 mmo/L, glucose 11.8 g/L. The ultrafiltration rate was set based on the patients' hemodynamic state. The ultrafiltration volume was determined according to the patient's infusion volume, urine output, blood pressure and edema. The ultrafiltration volume was about 2,500-5,000 mL. Before CBP therapy, low-molecular-weight heparin calcium was injected at an initial dose of 2,000 U to 4,000 U and a maintenance dose of 200 U/h to 400 U/h. Activation clotting time (ACT) was maintained between 150 and 200 seconds. Patients who developed coagulation disorders or active bleeding were switched to nonheparin hemofiltration, with the hemofilter being cleaned using 0.9% sodium chloride every 30 minutes.
Serum collection
Ten milliliters of venous blood samples were taken from the patients at 0, 12 and 24 hours during the first CBP treatment, as well as from the normal controls. Then the serum was centrifuged at 2,000 rpm for 5 minutes and stored in a refrigerator at -80°C. 
DAO and endotoxin, TNF-α assay
Serum DAO was determined by enzyme-linked immunosorbent assay (kit from Jiangcheng, Nanjing, PR China), and the serum endotoxin level was determined by quantitative colorimetric limulus test (Xiamen Houshiji). TNF-α was determined using Enzyme-linked Immunosorbent Assay (ELISA) (Sigma-Aldrich). The measurements were done according to the manufacturer's protocols.
Cell culture
Human Caco-2 cells were obtained from the Department of Molecular and Cellular Biology, at the Institute of Biochemistry and Cell Biology Academia, Shanghai, PR China. Cells were cultured and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 50 U/mL penicillin, 50 ug/mL streptomycin and 1% (v/v) nonessential amino acids (Gibco Laboratories) at 37°C in an atmosphere of 5% carbon dioxide.
Permeability of the intestinal epithelial monolayer
Permeability of the Caco-2 monolayer was studied in a Coaster Transwell® system (13) . In brief, 1 × 106/cm 2 Caco-2 cells were seeded on gelatin-coated membranes in doublechamber tissue culture plates (Transwell® membrane, 0.4 μM function pore size; Millipore). After being cultured for 21 days to a confluent monolayer, the Caco-2 cells were examined under the microscope for integrity and uniformity, and cultured for an additional 6 hours with 10% serum from patients. Then the media was changed and 1 mg/mL FITC-conjugated BSA (Mr 42,000; Sigma-Aldrich) was added to the upper chamber as a tracer. After 6 hours of incubation, penetration through the cell monolayer into the lower chamber was measured by a fluorometer (Dainippon Sumitomo Pharm). The permeability index (PI) was calculated as follows: PI = protein concentration in lower chamber/protein concentration in upper chamber.
Immunofluorescent staining and confocal microscopy
To detect stress fibers, Caco-2 cells grown on poly-Dlysine hydrobromide-coated glass cover slips were fixed in 4% formaldehyde and permeabilized with 0.2% triton X-100. Next, the cells were incubated overnight at 4°C with primary antibodies against claudin-1 (1:100 dilutions) (Santa Cruz Biotech). After being thoroughly washed with phosphatebuffered saline solution, the cells were incubated with fluorescein isothiocyanate (FITC) labeled as secondary antibody (1:100 dilution) (Wuhan Boster Biological Technology) for 2 hours under light-shielded conditions. F-actin was stained with Phalloidin-TRITC (Sigma-Aldrich) for 45 minutes at room temperature. Cells were visualized under a confocal laser scanning microscope (Olympus).
Western blotting analysis
After the confluent Caco-2 cells were treated with serum from patients and controls for 6 hours, ice-cold protein extraction buffer (KeyGen Biotech) supplemented with 1% protease inhibitor and 1% phosphorylate inhibitor was added for protein extraction. Proteins were separated by electrophoresis in 10% for F-actin or 10% (for claudin-1) trisglycine polyacrylamide gradient gels. The separated proteins were then transferred onto nitrocellulose membrane (Invitrogen), and blocked for 1 hour with TBS-Tween containing 5% bovine serum albumin. Next, the membrane was incubated overnight at 4°C with specific primary antibodies for F-actin (1:200 dilution) and claudin-1 (1:200 dilution) (Santa Cruz Biotech). After washing, the membrane was incubated at room temperature for 1 hour with horseradish peroxidase (HRP)-labeled as secondary goat anti-rabbit antibody (1:1,000 dilution) with blocking buffer (Wuhan Boster Biological Technology), and was then used for the detecting protein expression by use of a chemiluminescent staining reagent kit (Shanghai Beyotime). The average pixel density was analyzed with UN-SCAN-IT gel analysis software (Silk Scientific).
Inducible Rho kinase (ROCK) mRNA analysis by real-time PCR
The total RNA of the epithelial cells was isolated by means of TRIzol (Takara Biotech) and was reverse-transcribed with oligo (dT) primers and SuperScript® reverse transcriptase ( Invitrogen). TaqMan® primers and probes (Applied Biosystems) and samples were analyzed with the ABI prism 7900 sequence detection system (Applied Biosystems). The following primer pairs were used: ROCK forward: 5'GCCGCCGTTGC-CATATTAAG 3', and ROCK reverse: 5'CGGGCAAAAGGGTCTG-GAGC 3'. GAPDH was used as an internal control. Results were calculated using the comparative cycle threshold method and expressed as relative mRNA expression compared with control cells.
Statistical analysis
Analyses were performed with SPSS Version 13.0. All data were displayed as the mean ± SD. Two groups of data were compared by using t-test; multiple groups of data were compared with ANOVA. P<0.05 was considered statistically significant.
Results
Clinical characteristics
The APACHE II score was used to assess the condition of the patients and whether the condition was relieved after CBP treatment. The APACHE II score decreased significantly after CBP (before CBP: 17.58 ± 6.52, after CBP: 11.63 ± 3.06, p<0.05). Compared with before CBP, PaO 2 /FiO 2 increased significantly after CBP (p<0.05), while plasma bicarbonate (HCO 3 -) was significantly increased, serum creatinine (Scr), alanine aminotransferase (ALT) were significantly reduced (p<0.05). When CBP therapy began, 14 patients required norepinephrine as vasopressor therapy. Norepinephrine doses were reduced and ceased in 12 patients during CBP treatment (Tab. II).
Intestinal mucosa barrier function in SAP patients with MODS
Intestinal mucosa barrier dysfunction was evident in SAP patients with MODS compared with normal controls. SAP patients had remarkably elevated levels of serum DAO and endotoxin compared with normal controls. During the course of CBP treatment, levels of serum DAO and endotoxin declined gradually. Serum DAO and endotoxin levels were reduced significantly in the 24-hour CBP groups compared with those in the pre-CBP group (p<0.05; Tab. III). On the other hand, the permeability index (PI) of intestinal epithelial monolayer increased when treated with serum from SAP patients with MODS compared with those in the control group (p<0.05). During the course of CBP treatment, the PI level was reduced significantly in the 12-hour CBP and 24-hour CBP groups compared with that in the pre-CBP group (p<0.05; Tab. III).
Changes in the serum TNF-α level in SAP patients with MODS
As shown in Table III , SAP patients with MODS had remarkably elevated levels of TNF-α compared with normal controls (p<0.05). During the course of CBP treatment, levels of TNF-α declined gradually. A marked decline in serum TNF-α levels were seen in the 24-hour CBP group (p<0.05).
The effects of CBP on the distribution of F-actin cytoskeleton in intestinal epithelial monolayer induced by serum from SAP patients with MODS
As shown in Figure 1 , cells were treated with serum from healthy controls, showing that actin is evenly distributed in the nucleus periphery, forming a peripheral actin ribbon (Fig. 1A) . Cells were treated with serum from SAP patients with MODS before CBP treatment, showing obvious redistribution of the actin cytoskeleton with the increased information of numerous long, dense F-actin stress fibers both in number and density throughout the whole cell. (Fig. 1B) . However, these changes were markedly reduced in intestinal epithelial monolayer from the 12-hour and 24-hour CBP groups, demonstrating that CBP improved stress fiber reorganization. (Figs. 1C and D) .
The effects of CBP on the expression of claudin-1 in intestinal epithelial monolayer induced by serum from SAP patients with MODS
The control group showed claudin-1 had been mainly distributed at the periphery of epithelial cells and formed a smooth and continuous tight junction band at the contact position between adjacent cells ( Fig. 2A) . By contrast, changes in the distribution of claudin-1 were observed in the pre-CBP group, including fading, intermittent continuity, fragmentation, and loosened intercellular junction (Fig. 2B) . However, enhanced staining of claudin-1and improvement in the irregularity and breakage of tight junction were observed in the 24-hour-CBP group. (Figs. 2C and D) .
F-actin and claudin-1 expression in intestinal epithelial monolayer
Compared with the control group, the expression of F-actin had no change (p>0.05). Moreover, in the 12-hour and 24-hour CBP group, the expression of F-actin still had no change compared with that in the pre-CBP group (p>0.05). Compared with the control group, the expression of claudin-1 significantly decreased in the pre-CBP group (p<0.05). In the 24-hour CBP group, the expression of claudin-1 was significantly increased compared with that in the pre-CBP group (p<0.05), but still lower than the control group (Figs. 3  and 4) .
ROCK mRNA expression in the intestinal epithelial monolayer treated with serum from SAP patients with MODS
As shown in Figure 5 , ROCK mRNA was significantly increased compared with the control group (p<0.05). However, in the 24-hour CBP group, ROCK mRNA was significantly reduced compared with that in the pre-CBP group (p<0.05). 
Discussion
As a common critical acute abdominal disease, severe acute pancreatitis (SAP) has a high mortality, which is associated with systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) (1) . Recent studies have demonstrated that the direct threats to SAP patients include translocation of intestine bacterial, intestinederived endotoxemia and secondary pancreatic infections rather than the pancreatic necrosis. In SAP, the increased intestinal permeability may allow the shifting of intestinal bacteria, toxins and inflammatory mediators from the gut to the systemic circulation, where they induce endogenous and suicidal SIRS, even MODS. Thus, the intestine is considered to be a "critical organ" of SIRS and MODS as well as an "amplifier" of inflammatory mediators (2) . The increased intestinal permeability is associated with an increased risk for complications, SIRS, MODS or even mortality in SAP patients (3) . It is crucial to explore effective therapies to prevent intestinal mucosal barrier dysfunction-derived SIRS and MODS caused by SAP.
Although progress continues to be made in the treatment of SAP, the mortality rate associated with MODS is still high. Recently, clinical studies have shown that continuous blood purification (CBP) may be beneficial to attenuate systemic complication in SAP patients (8, 9) . In this study, we performed CBP on SAP patients with MODS and found that CBP treatment is helpful to improve organ functions (such as lung function, renal function, and hepatic function), to maintain homeostasis, and to lessen the severity of disease. Since intestinal epithelial cell dysfunction has an important role in the development of MODS potentially resulting from SAP, serum DAO and endotoxin, the markers that reflect intestinal mucosal injury, were detected in the present study (5, 6), and intestinal epithelial monolayer permeability was analyzed in a Transwell® system. We found that the levels of serum DAO and endotoxin were remarkably elevated in SAP patients with MODS, and the permeability index (PI) level increased significantly in Caco-2 stimulated by serum from SAP patients with MODS. The results imply that intestinal mucosal barrier dysfunction may be one of the critical pathophysiologic disorders in SAP patients with MODS.
Intestinal epithelial monolayer permeability is regulated by actin stress fibers and intercellular junctions (17) . The important component of intercellular junctional complexes is tight junctions, which are required for the formation of intestinal epithelial barriers. The main functions of tight junctions are to close adjacent cell fissures and effectively prevent infiltration of macromolecular material along the cell gap (18) . It is composed of a variety of transmembrane proteins including claudin-1, occludin, and junction adhesion molecule. Tight junctions are linked intracellularly to the actin cytoskeleton to maintain cellular morphology and regulate cellular permeability (19) . The inflammatory mediators can cause F-actin recombination, which causes cell contraction, cell-cell tight junction to become loose, cell gap formation, and transport of macromolecules through the epithelial cell pathway. At the same time, epithelial cell contraction also caused thinning of the cell membrane, promote the formation of cell-penetrating channels, making macromolecules into the cells, thereby increasing the permeability of the epithelium (20) .
We examined the distribution of F-actin and claudin-1 by confocal microscopy and found stress fiber reorganization that included thickening and bundling of the F-actin cytoskeleton throughout the whole cell. We also found that claudin-1 distribution on cells became discontinuous when induced by serum from the SAP patients with MODS. On the other hand, the expression of F-actin had no change, but the claudin-1 decreased. This means that claudin-1 not only changed in cellular morphology and structure, but also decreased in its expression, and F-actin changed only in cellular morphology and structure. These cellular actin and tight junction proteins changes could alter the integrity of the intestinal epithelium, further leading to collapse of the intestinal epithelial barrier, which results in increased intestinal epithelial permeability (21) .
The RhoA/ROCK signaling pathway is a member of the GTPases family, which plays an important role in a variety of cellular processes, including cell proliferation, cell migration, etc. (22) . Rho kinase (ROCK) is the downstream effector of RhoA. Activated ROCK can increase phosphorylation of myosin light chain (MLC) and inhibit myosin light phosphatase, which induces F-actin and tight junction structural protein reorganization (23) . Some reports also showed that ROCK may increase endothelial monolayer permeability by disrupting intercellular junction and F-actin (24) . In the present study we found that ROCK mRNA significantly increased in intestinal epithelial monolayer induced by serum from the SAP patients with MODS, coupled with intestinal epithelial hyperpermeability and F-actin and claudin-1 reorganization. This indicated that RhoA/ROCK activation may play an important role in modulating intestinal epithelial hyper-permeability induced by the serum from the SAP patients with MODS.
Inflammatory mediators, including TNF-α, thrombin, IL-1β and IL-6 can increase vascular permeability primarily by activated RhoA/ROCK (25) . The changes of serum TNF-α in SAP patient with MODS were detected. The results show the level of serum TNF-α was higher in SAP patients with MODS than in controls. As one of the important proinflammatory cytokines, TNF-α can increase intestinal permeability, and evokes disruption of the intestinal epithelial barrier function (26) . Therefore, releasing of proinflammatory cytokines (27) might be responsible for intestinal epithelial hyper-permeability induced by the serum of SAP patients via RhoA/ROCK activation-mediated F-actin remodeling.
It was found that the APACHE II score in SAP patients with MODS decreased significantly after 24 hours of CBP therapy. Significantly reduced levels of serum DAO, endotoxin, and intestinal epithelial monolayer permeability were also found in these SAP patients with MODS after CBP therapy. These findings suggest that CBP therapy can not only improve the general condition but also improve the intestinal mucosa barrier dysfunction in SAP patients with MODS. DAO has been proven to be an excellent early marker for evaluating the severity of intestinal mucosa injury, which has a large molecular weight of 250 KD (28) , and thus, serum DAO cannot be cleared by diffusion and convection directly during CBP. A decreased DAO level may reflect improved intestinal mucosa barrier function. Because of its high molecular weight, endotoxins cannot be removed by filtration processes (29) . Furthermore, absorptive removal of this molecule cannot be ruled out. Our study revealed that levels of endotoxin decreased gradually during CBP therapy, suggesting that CBP improved the intestinal mucosa barrier and therapy restrained enterogenous endotoxemia.
On the other hand, we also found that after CBP treatment, the formation of F-actin stress fibers lessened in those cells both in number and density, the breakdown and reorganization of claudin-1 had been attenuated and the expression of claudin-1 increased. These imply that CBP decreased intestinal epithelial permeability through lessening abnormal F-actin aggregate formation, decreasing the breakdown and reorganization of tight junction structural proteins and increasing the expression of tight junction structural proteins. Furthermore, downregulating expression of Rock mRNA was observed in the 24-hour CBP groups. All of these results imply that CBP can reduce intestinal epithelial hyper-permeability in SAP patients with MODS by inhibiting ROCK-mediated F-actin and tight junction structural protein remodeling.
The proinflammatory cytokines such as TNF-α, thrombin, IL-1β, and IL-6 are related to increasing the intestinal epithelial permeability, which can induce transcription of genes encoding RhoA/ROCK. Some studies show that the increased levels of plasmaTNF-α, thrombin, IL-1β, and IL-6 in patients with SAP can be attenuated by CBP (30, 31) . This effect was related to the adsorption of the membrane (32) , and some studies also found increasing ultrafiltration volume or dialysate flow led to a significant increase in cytokine clearances (33) . This means that cytokine clearances are to a large extent dependent upon the membrane material and the convective flux (ultrafiltration volume). Our study also found serum TNF-α levels were higher in patients with SAP, but gradually declined during the course of CBP treatment. This suggests that the removal of such excess inflammatory factors by CBP may also play an important role in reducing the expression of ROCK mRNA, and thereby attenuating intestinal mucosal injury, corresponding to the results we previously demonstrated (34) .
Conclusions
In conclusion, the results from this study demonstrate that CBP therapy can serve as a useful adjunct to the treatment of SAP. This benefit may be related to its improvement in intestinal mucosal dysfunction, potentially reducing the development of SIRS and MODS. The inhibition of ROCK-mediated F-actin and tight junction structural protein remodeling might be one of important mechanisms, which may be related to the removal of TNF-α by CBP. However, due to the lack of large samples and randomized, controlled experiments, it is very difficult to separate the effects from CBP treatment that directly affect the intestinal mucosa, or supportive treatment that improved the conditions in the cohort study. More multicenter, randomized controlled trials are expected to prove the findings.
